MedPath

Effect of Stillingia Sylvatica VersusHomoeopathic Individual medicines in theReduction of Symptom Severity of Rheumatoid Arthritis

Phase 3
Conditions
Health Condition 1: M056- Rheumatoid arthritis with involvement of other organs and systems
Registration Number
CTRI/2023/11/059776
Lead Sponsor
Dr Candy Benny
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1. Those patients satisfying 2010 ACR/EULAR criteria for Rheumatoid Arthritis.

2. Subjects belonging to both sexes.

3. Patients belonging to the age group 20-70 years.

Exclusion Criteria

1. Cases associated with malignancies, severe illnesses like renal failure, hepatic failure.

2. Pregnant females.

3. Cases with disease activity score 28 value more than 7.5(high disease

activity)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath